APA (7th ed.) Citation

JC, S., J, Z., R, P., B, H., C, F., D, H., . . . P, R. (2010). Treatment with granulocyte-macrophage colony-stimulating factor is associated with reduced indoleamine 2,3-dioxygenase activity and kynurenine pathway catabolites in patients with severe sepsis and septic shock. Scandinavian Journal of Infectious Diseases, 42(3), 164. https://doi.org/10.3109/00365540903405768

Chicago Style (17th ed.) Citation

JC, Schefold, et al. "Treatment with Granulocyte-macrophage Colony-stimulating Factor Is Associated with Reduced Indoleamine 2,3-dioxygenase Activity and Kynurenine Pathway Catabolites in Patients with Severe Sepsis and Septic Shock." Scandinavian Journal of Infectious Diseases 42, no. 3 (2010): 164. https://doi.org/10.3109/00365540903405768.

MLA (9th ed.) Citation

JC, Schefold, et al. "Treatment with Granulocyte-macrophage Colony-stimulating Factor Is Associated with Reduced Indoleamine 2,3-dioxygenase Activity and Kynurenine Pathway Catabolites in Patients with Severe Sepsis and Septic Shock." Scandinavian Journal of Infectious Diseases, vol. 42, no. 3, 2010, p. 164, https://doi.org/10.3109/00365540903405768.